Supplementary Figure 6 from An Antibody That Locks HER3 in the Inactive Conformation Inhibits Tumor Growth Driven by HER2 or Neuregulin Andrew P. Garner , Carl U. Bialucha , Elizabeth R. Sprague , Joan T. Garrett , Qing Sheng , Sharon Li , Olga Sineshchekova , Parmita Saxena , Cammie R. Sutton , Dongshu Chen , Yan Chen , Huiqin Wang , Jinsheng Liang , Rita Das , Rebecca Mosher , Jian Gu , Alan Huang , Nicole Haubst , Carolin Zehetmeier , Manuela Haberl , Winfried Elis , Christian Kunz , Analeah B. Heidt , Kara Herlihy , Joshua Murtie , Alwin Schuller , Carlos L. Arteaga , William R. Sellers , Seth A. Ettenberg crossref（2023）
摘要
PDF file - 416K, Figure S6. Trastuzumab/LJM716 combination inhibits 3D spheroid growth of breast cancer cell lines more effectively than trastuzumab/pertuzumab combination.
更多 查看译文
AI 理解论文
溯源树
样例
